S01: Application of Healthcare Ethics: Consults, Cases, & Choices

Army Chaplain Maj. Vincent Bain, Ph.D., M.Div., M.B.E.
Bioethics Advisor
Healthcare Ethics Committee Co-Chair
Walter Reed National Military Medical Center
Bethesda, MD

Brigid Herrick, M.P.H., M.S., C.P.X.P.
Chief Experience Officer
Healthcare Ethics Committee Co-Chair
Walter Reed National Military Medical Center
Bethesda, MD

Learning objectives:

1. Summarize the purpose of a health care ethics consultation.
2. Identify ethical concerns within medical cases.
3. Discuss the implications of responses to ethical concerns.

S02: Naltrexone Injection for Opioid Use Disorder: FDA’s Efforts to Reduce Medication Errors

U.S. Public Health Service Cmdr. Jessica Voqui, Pharm.D., M.S., R.A.C.
Associate Director for Postmarket Regulatory Science
Office of New Drugs
Division of Anesthesiology, Addiction Medicine, and Pain Medicine,  Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Sofanit Getahun, Pharm.D., B.C.P.S.
Safety Evaluator
Office of Medication Error Prevention and Risk Management
Office of Surveillance and Epidemiology
Division of Medication Error Prevention and Analysis 1
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

U.S. Public Health Service Cmdr. Mark A. Liberatore, Pharm.D., R.A.C.
Deputy Director for Safety
Office of New Drugs
Division of Anesthesiology, Addiction Medicine, and Pain Medicine,  Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

U.S. Public Health Service Lt. Cmdr. Valerie S. Vaughan, Pharm.D.
Team Leader
Office of Medication Error Prevention and Risk Management
Office of Surveillance and Epidemiology
Division of Medication Error Prevention and Analysis 1
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Learning objectives:

1. Discuss the opioid crisis and the importance of medications used to treat opioid use disorder.
2. Describe postmarket drug safety authorities and postmarket medication error surveillance.
3. Illustrate how the FDA’s process for identifying and evaluating postmarket safety issues is applied
   for medication errors.
4. Recognize how postmarket safety information can be used to change product labeling.
5. Summarize how healthcare providers can contribute to drug safety within their practice.

S03: Motivational and Trauma-Informed Strategies to End Intimate Partner Violence in Service Members and Veterans

Casey Taft, Ph.D.
Clinical Research Psychologist
National Center for Posttraumatic Stress Disorder, VA Boston Healthcare System
Professor of Psychiatry, Boston University School of Medicine
Boston, MA

Learning objectives:

1. Explain the social information processing and survival models for violence for survivors of trauma
   and their partners.
2. Identify contributing factors that can increase risk for intimate partner violence among survivors of
   trauma and their partners.
3. Describe a strategy for motivating those who use intimate partner violence to increase their
   engagement in the therapy process.

S04: Primary Care Behavioral Health: Program Overview and Best Practices

1. Summarize the Primary Care Behavioral Health Program (PCBH) primary goals as it relates to patient care in the Primary Care setting.
2. Compare Behavioral Health Consultants (BHCs) and Behavioral Health Care Facilitators (BHCFs) models and roles that make up the PCBH Program.
3. Differentiate Specialty Behavioral Health (SBH) and PCBH in regards to scope of care.
4. Summarize best practices regarding how to optimize the PCBH Program, including use of warm handoffs.

U.S. Public Health Service Capt. Aditya Bhagwat, Ph.D., A.B.P.P.-C.N.
Program Manager, Primary Care Behavioral Health, DHA
Falls Church, VA

U.S. Public Health Service Cmdr. Sara Pulliam, Psy.D., A.B.P.P.
Program Manager, Primary Care Behavioral Health, DHA
Falls Church, VA

June Taheri, M.D.
Program Manager, Primary Care Behavioral Health, DHA
Falls Church, VA

S05: Managing Musculoskeletal Injuries: Lessons Learned from the Air Force’s Special Warfare Human Performance Support Group

1. Identify the role of wearable technology in the recognition of musculoskeletal injuries.
2. Discuss the current state of motion capture and force plate technology in the prevention and recognition of musculoskeletal injuries.
3. Summarize the benefits and challenges of a holistic model in the prevention and management of musculoskeletal injuries.

Air Force Lt. Col. Cody Butler, Ph.D., D.P.T., S.C.S., C.S.C.S.
Research Flight Commander, Special Warfare Training Wing
Lackland Air Force Base, TX